A clinic specializing in midlife women’s health, Midi Health, has partnered with Neurotrack, a digital cognitive assessment company, to help women determine if their brain fog symptoms are related to menopause or could be signs of early dementia. This collaboration allows Midi Health clinicians to send patients a quick Neurotrack cognitive screening that can be completed on a smartphone, tablet, or computer in just three minutes, compared to traditional screenings that can take up to 20 minutes.
Patients who receive low scores on the Neurotrack screening will be referred to providers for a more detailed evaluation. Chief Medical Officer Kathleen Jordan emphasizes that while brain fog during menopause is common, it does not necessarily indicate a higher risk of dementia. For most women, the screening provides reassurance, but for some, it could help detect early signs of dementia, which benefit from early treatment.
Midi Health recently secured $25 million in Series A funding to expand access to its services nationwide and has received support from Google Ventures, Operator Collective, Felicis, and others. Neurotrack, based in Silicon Valley, raised $10 million in 2022 and has partnered with insurance provider Nationwide to simplify the long-term care underwriting process. Their cognitive screening process has significantly reduced the time needed for evaluations, making it more efficient and accessible for patients.
